Synjardy tablets receive FDA approval for adults with type 2 diabetes
27 August 2015 | By Nick Jackson
Synjardy approval was based on multiple clinical trials showing reductions in blood glucose versus placebo...
List view / Grid view
27 August 2015 | By Nick Jackson
Synjardy approval was based on multiple clinical trials showing reductions in blood glucose versus placebo...
20 August 2015 | By Victoria White
Boehringer Ingelheim and Lilly have announced positive top-line results from a clinical study investigating cardiovascular (CV) outcomes for Jardiance...
17 August 2015 | By Victoria White
New data show Spiolto Respimat provides consistent, clinically meaningful improvements in quality of life versus placebo in patients COPD...
28 July 2015 | By Victoria White
Boehringer Ingelheim has entered an exclusive and collaboration agreement for the development and global commercialisation rights of HM61713...
24 July 2015 | By Victoria White
An independent expert review of alteplase has provided a firm reassurance that it is safe and effective for use up to 4.5 hours after the onset of symptoms...
16 July 2015 | By
Boehringer Ingelheim has welcomed new international treatment guidelines for IPF which suggest that clinicians use Ofev in patients with the disease...
6 July 2015 | By Victoria White
Results from the LUX-Lung 8 Trial demonstrate that afatinib resulted in superior progression-free survival and overall survival compared to erlotinib...
2 July 2015 | By Victoria White
Boehringer Ingelheim today announced regulatory authority approvals for Spiolto Respimat (tiotropium/olodaterol) in a number of European countries...
1 July 2015 | By Victoria White
Vitae has announced top-line efficacy results from the metformin arm of a trial of BI187004/VTP-34072 in the treatment of patients with type 2 diabetes...
22 June 2015 | By Victoria White
Results from an interim analysis of a Phase III study demonstrate that idarucizumab immediately reversed the anticoagulant effect of dabigatran...
16 June 2015 | By Victoria White
Results from a healthy volunteer study investigating the reversal of the anticoagulant effect of Pradaxa by idarucizumab have been published...
3 June 2015 | By Victoria White
Boehringer Ingelheim’s VARGATEF in combination with docetaxel has been recommended for use within the National Health Service (NHS) in England and Wales...
28 May 2015 | By Victoria White
Synjardy has been granted marketing authorisation by the European Commission for the treatment of adults with type 2 diabetes (T2D) in the European Union...
28 May 2015 | By Victoria White
The US Food and Drug Administration has approved Boehringer Ingelheim’s once-daily Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray...
21 May 2015 | By Victoria White
New data shows tiotropium/olodaterol Respimat provides lung function benefit to patients with COPD from the start of maintenance therapy...